CAMBRIDGE -- The lords and ladies of life sciences turned the courtyard outside Takeda Oncology’s headquarters on Landsdowne Street into a biotech playground Thursday evening as the Japanese drug maker hosted an invitation-only reception with its top executives.
Takeda’s chief executive Christophe Weber and Andy Plump, the company’s new chief medical and scientific officer, greeted about 250 guests. “We know the creativity and energy is unique here,” Weber, a French national, told the Massachusetts biotech crowd.
Among those chatting up the Takeda brass and mingling on the grass with drinks and hors d’oeuvres were MIT provost Marty Schmidt, associate provost Karen Gleason, state economic development director Jay Ash, MassBio president Bob Coughlin, Atlas Venture partner Jason Rhodes, state Representative Jay Livingstone, ImmunoGen execs John Lambert and Sandra Poole, and Alnylam strategy chief Marko Kozul.
Also spotted in the crowd were Pfizer’s former Cambridge site leader Jose Carlos Gutierrez-Ramos, who recently signed on as chief executive of Synlogic, and former Massachusetts Life Sciences Center president Susan Windham-Bannister.
“Once you partner with us, [you’ll see] we’re the best partner,” Plump told Takeda’s visitors as a trio of musicians, playing guitar, saxophone and, upright bass, serenaded the crowd and Rhode Island event painter Mark DeSilva worked to capture the scene in a portrait.
“Ninety-five percent of what I do is weddings,” DeSilva said. “I paint the first dance. I’ve done a christening, I’m doing a bar mitzvah. This is my first corporate gig.”